THE USE OF CULTURED HUMAN ENDOTHELIAL-CELLS AND HEPATOCYTES AS AN INVITRO MODEL SYSTEM TO STUDY MODULATION OF ENDOGENOUS FIBRINOLYSIS

被引:32
作者
KOOISTRA, T
机构
[1] T. Kooistra, Gaubius Institute TNO, NL-2300 AP Leiden
关键词
Endogenous fibrinolysis; Endothelial cells; Hepatocytes; Tissue-type plasminogen activator (t-PA); Tissue-type plasminogen activator inhibitor 1(PAI-1);
D O I
10.1016/0268-9499(90)90352-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue-type plasminogen activator (t-PA) plays a pivotal role in the onset of fibrinolysis. Regulation of t-PA activity in the bloodstream occurs at various levels, including release from the endothelium and, to some extent, interaction with a specific inhibitor, PAI-1. Modulation of the fibrinolytic capacity in plasma (endogenous fibrinolysis) would be a powerful means in preventing thrombosis. This paper describes the use of cultured human endothelial cells and hepatocytes as in vitro model systems to study regulation of t-PA and PAI-1 synthesis. Evidence is provided that these models represent useful alternatives for the use of experimental animals in finding compounds that might stimulate endogenous fibrinolysis in humans. These in vitro systems allow detailed studies of regulatory mechanisms, and it is shown that the t-PA synthesizing capacity of endothelial cells is only partially exploited, suggesting that stimulation of endogenous fibrinolysis is feasible. Also, some progress has been made in developing an in vitro system for studying the acute, i.e. within minutes, release of t-PA from endothelial cells and the state of the art of this model is discussed. © 1990.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 83 条
  • [31] INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION
    HAMSTEN, A
    WIMAN, B
    DEFAIRE, U
    BLOMBACK, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) : 1557 - 1563
  • [32] HANSS M, 1987, J LAB CLIN MED, V109, P97
  • [33] RELATIONSHIP BETWEEN AGE AND PLASMA T-PA, PA-INHIBITOR, AND PA ACTIVITY
    HASHIMOTO, Y
    KOBAYASHI, A
    YAMAZAKI, N
    SUGAWARA, Y
    TAKADA, Y
    TAKADA, A
    [J]. THROMBOSIS RESEARCH, 1987, 46 (05) : 625 - 633
  • [34] CALCIUM DEPENDENT AND INDEPENDENT RELEASE OF PLASMINOGEN ACTIVATOR FROM VASCULAR WALL
    IZAKI, S
    KITAGUCHI, H
    [J]. THROMBOSIS RESEARCH, 1977, 10 (05) : 765 - 770
  • [35] JESPERSEN J, 1985, THROMB HAEMOSTASIS, V54, P454
  • [36] JESPERSEN J, 1986, THROMB HAEMOSTASIS, V55, P388
  • [37] JUHANVAGUE I, 1987, DIABETES METAB, V13, P331
  • [38] THE POSTOPERATIVE FIBRINOLYTIC SHUTDOWN - A RAPIDLY REVERTING ACUTE PHASE PATTERN FOR THE FAST-ACTING INHIBITOR OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR AFTER TRAUMA
    KLUFT, C
    VERHEIJEN, JH
    JIE, AFH
    RIJKEN, DC
    PRESTON, FE
    SUELING, HM
    JESPERSEN, J
    AASEN, AO
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (07) : 605 - 610
  • [39] KLUFT C, 1988, THROMB HAEMOSTASIS, V59, P329
  • [40] PLASMINOGEN-ACTIVATOR INHIBITOR IS ASSOCIATED WITH THE EXTRACELLULAR-MATRIX OF CULTURED BOVINE SMOOTH-MUSCLE CELLS
    KNUDSEN, BS
    HARPEL, PC
    NACHMAN, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04) : 1082 - 1089